Allianz’s CureVac CVAC Stock Holding History

Allianz’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-90	Closed	-$407	–	480
2025 Q4	$407	Hold	90	–	–	﹤0.01%	431
2025 Q3	$485	Hold	90	–	–	﹤0.01%	372
2025 Q2	$489	Hold	90	–	–	﹤0.01%	387
2025 Q1	$249	Hold	90	–	–	﹤0.01%	417
2024 Q4	$307	Hold	90	–	–	﹤0.01%	432
2024 Q3	$265	Hold	90	–	–	﹤0.01%	376
2024 Q2	$306	Hold	90	–	–	﹤0.01%	452
2024 Q1	$273	Buy	+90	New	+$316	﹤0.01%	450

Allianz's CVAC Position: Q1 2026 in Review

Allianz sold out of CureVac (CVAC) in Q1 2026, closing a stake of 90 shares — an estimated $407 sold.

Allianz first reported a position in CVAC in Q1 2024 and held it in 8 quarters. The position peaked at $489 in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Allianz reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Allianz sold 90 CureVac shares in Q1 2026, an estimated $407.
Allianz first reported a position in CureVac in Q1 2024 and held it in 8 quarters.
Allianz's CureVac position peaked at $489 in Q2 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Allianz's 13F filing for Q1 2026, filed 11 May 2026.